EMAIL THIS PAGE TO A FRIEND

Environmental toxicology and pharmacology

Association of methamidophos and sleep loss on reproductive toxicity of male mice.


PMID 21843794

Abstract

This study investigated the effects of organophosphate exposure on the male reproductive system of mice submitted to chronic sleep loss condition. Adult Swiss mice were distributed into 4 groups: control; methamidophos (MTP); sleep restriction (SR); and MTP+SR. The dose of methamidophos was 0.002 mgkg(-1)day(-1) (half of the Acceptable Daily Intake). Sleep restriction condition was 21 h day(-1) during 15 days. In relation to control group, MTP treatment induced a significant reduction of 12% on morphologically normal spermatozoa in both MTP and MTP+SR groups. In addition, the absolute and relative weights of the seminal vesicles were decreased (MTP, -34%; MTP+SR, -45%). Epididymal fat was reduced in SR groups (SR, -64%; MTP+SR, -58%). Plasma testosterone levels were significantly decreased in MTP and SR groups, and progesterone levels were increased 8 times in MTP+SR in comparison with the control group. The corticosterone levels were unaffected by MTP or SR conditions. Thus, low dose MTP exposure resulted in deleterious effects on the male reproductive system. Sleep loss associated with MTP potentiated the effect on steroidogenesis, mainly in terms of progesterone levels.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N12393
Methamidophos, analytical standard
C2H8NO2PS
33395
Methamidophos, PESTANAL®, analytical standard
C2H8NO2PS